Related Experiment Video
Updated: Jun 8, 2026
10:22
Methods to Investigate the Regulatory Role of Small RNAs and Ribosomal Occupancy of Plasmodium falciparum
Published on: December 4, 2015
A mathematical model for antimalarial drug resistance
Jean M Tchuenche1, Christinah Chiyaka, David Chan
1Mathematics Department, University of Dar es Salaam, PO Box 35062, Dar es Salaam, Tanzania. jmtchuenche@gmail.com
Mathematical Medicine and Biology : a Journal of the IMA
|October 2, 2010
Summary
Mathematical modeling of malaria reveals that increasing treatment offers limited benefits against resistant parasite strains, especially in high transmission areas. This challenges disease elimination strategies, even with a basic reproduction number below one.
Area of Science:
- Epidemiology
- Mathematical Biology
- Infectious Disease Modeling
Background:
- Malaria remains a significant global health challenge.
- Drug resistance in malaria parasites complicates control efforts.
- Understanding the dynamics of drug resistance is crucial for effective interventions.
Purpose of the Study:
- To develop and analyze a mathematical model for malaria incorporating treatment and multiple levels of parasite resistance.
- To investigate the impact of treatment strategies on disease dynamics in the presence of resistance.
- To explore the phenomenon of backward bifurcation in malaria transmission.
Main Methods:
- Formulation of a compartmental mathematical model for malaria transmission.
- Inclusion of both drug-sensitive and drug-resistant parasite strains.
- Analytical and quantitative analysis of model dynamics, including equilibrium states and bifurcation analysis.
Main Results:
- The model demonstrates backward bifurcation, where a stable disease-free equilibrium coexists with a stable endemic equilibrium.
- A basic reproduction number less than unity is insufficient for malaria elimination when resistance is present.
- Increasing treatment levels shows diminishing returns in high transmission settings with resistant strains.
Conclusions:
- Treatment strategies must account for parasite resistance to be effective.
- High transmission rates exacerbate the limited benefits of increased treatment in resistant malaria.
- Cost-benefit analyses for malaria treatment require careful consideration of resistance dynamics and transmission intensity.
Related Concept Videos
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:15Pharmacodynamic Models: Linear Concentration–Effect Model
The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
01:29Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:18Pharmacodynamic Models: Emax Drug–Concentration Effect Model
The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...